Immune dysregulation and potential targeted therapy in myelodysplastic syndrome.

Journal Information

Full Title: Ther Adv Hematol

Abbreviation: Ther Adv Hematol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the fundings from the National High Technology Research and Development Program of China (grant no. 2021YFA1101504 to Dr Yicheng Zhang), and the National Natural Science Foundation of China (grant no. 81873427 to Dr Jia Wei, grant no. 81873446 to Dr Yicheng Zhang, grant no. 81900133 to Dr. Ling Ma)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025